1. Home
  2. KRRO vs INVE Comparison

KRRO vs INVE Comparison

Compare KRRO & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • INVE
  • Stock Information
  • Founded
  • KRRO 2014
  • INVE 1990
  • Country
  • KRRO United States
  • INVE United States
  • Employees
  • KRRO N/A
  • INVE N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • KRRO Health Care
  • INVE Technology
  • Exchange
  • KRRO Nasdaq
  • INVE Nasdaq
  • Market Cap
  • KRRO 101.4M
  • INVE 82.2M
  • IPO Year
  • KRRO 2019
  • INVE 1997
  • Fundamental
  • Price
  • KRRO $12.35
  • INVE $3.09
  • Analyst Decision
  • KRRO Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • KRRO 7
  • INVE 3
  • Target Price
  • KRRO $85.67
  • INVE $6.50
  • AVG Volume (30 Days)
  • KRRO 203.4K
  • INVE 35.0K
  • Earning Date
  • KRRO 08-12-2025
  • INVE 08-07-2025
  • Dividend Yield
  • KRRO N/A
  • INVE N/A
  • EPS Growth
  • KRRO N/A
  • INVE N/A
  • EPS
  • KRRO N/A
  • INVE 3.12
  • Revenue
  • KRRO $4,821,000.00
  • INVE $25,239,000.00
  • Revenue This Year
  • KRRO $65.08
  • INVE N/A
  • Revenue Next Year
  • KRRO N/A
  • INVE $9.00
  • P/E Ratio
  • KRRO N/A
  • INVE $0.99
  • Revenue Growth
  • KRRO N/A
  • INVE N/A
  • 52 Week Low
  • KRRO $10.29
  • INVE $2.86
  • 52 Week High
  • KRRO $98.00
  • INVE $4.44
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 41.55
  • INVE 40.43
  • Support Level
  • KRRO $11.50
  • INVE $3.12
  • Resistance Level
  • KRRO $16.86
  • INVE $3.23
  • Average True Range (ATR)
  • KRRO 1.50
  • INVE 0.11
  • MACD
  • KRRO 0.01
  • INVE -0.02
  • Stochastic Oscillator
  • KRRO 31.35
  • INVE 0.00

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks: